PrEP-话题@MedSci

#PrEP#

18篇内容 | 1887人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2255900, encodeId=7bb82255900a8, content=<a href='/topic/show?id=edbd88e6e7' target=_blank style='color:#2F92EE;'>#HIV#</a> <a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a> <a href='/topic/show?id=b37c12186293' target=_blank style='color:#2F92EE;'>#来那卡帕韦#</a>, objectTitle=Lancet：新研究表明HIV预防药物来那卡帕韦的新配方可在人体内存留长达一年的时间, objectType=article, longId=866860, objectId=a90b86686057, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20250313/1741821279585_2185383.png, objectUrl=/article/show_article.do?id=a90b86686057, replyNumber=0, likeNumber=15, createdTime=2025-03-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1278904, encodeId=d25012e8904b8, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=J Clin Oncol：神经激肽-1受体拮抗剂fosnetupitant (FosNTP)对比fosaprepitant (FosAPR)预防高致吐性化疗引起的恶心和呕吐的有效性和安全性, objectType=article, longId=220833, objectId=ff7e22083386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff7e22083386, replyNumber=0, likeNumber=93, createdTime=2021-11-24, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff7e22083386, moduleTitle=J Clin Oncol：神经激肽-1受体拮抗剂fosnetupitant (FosNTP)对比fosaprepitant (FosAPR)预防高致吐性化疗引起的恶心和呕吐的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff7e22083386)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278903, encodeId=62c412e890373, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Lancet Infect Dis：cabotegravir的PrEP方案可将HIV发病率降低66％, objectType=article, longId=197267, objectId=597819e26795, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597819e26795, replyNumber=0, likeNumber=114, createdTime=2020-07-10, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597819e26795, moduleTitle=Lancet Infect Dis：cabotegravir的PrEP方案可将HIV发病率降低66％, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=597819e26795)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278902, encodeId=6f6212e890207, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Preprint：来自25个国家的研究：高咖啡摄入量竟会降低胃癌风险, objectType=article, longId=194491, objectId=e12b19449187, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e12b19449187, replyNumber=0, likeNumber=90, createdTime=2020-05-22, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e12b19449187, moduleTitle=Preprint：来自25个国家的研究：高咖啡摄入量竟会降低胃癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e12b19449187)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278901, encodeId=77bc12e890164, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Preprint：为什么COVID-19在欧洲的传播比在亚洲更广泛, objectType=article, longId=194088, objectId=433c19408814, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=433c19408814, replyNumber=0, likeNumber=98, createdTime=2020-05-15, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=433c19408814, moduleTitle=Preprint：为什么COVID-19在欧洲的传播比在亚洲更广泛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=433c19408814)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278900, encodeId=30ee12e890074, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Preprint：吸烟状态与COVID-19严重程度呈正比, objectType=article, longId=193070, objectId=8adc1930e089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8adc1930e089, replyNumber=0, likeNumber=103, createdTime=2020-04-29, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8adc1930e089, moduleTitle=Preprint：吸烟状态与COVID-19严重程度呈正比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8adc1930e089)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278899, encodeId=5ca112e8899c4, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Preprints: 利用对外源性RNA的转录反应预测RNA病毒的广谱抗病毒药, objectType=article, longId=191159, objectId=068319115937, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=068319115937, replyNumber=0, likeNumber=98, createdTime=2020-04-02, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=068319115937, moduleTitle=Preprints: 利用对外源性RNA的转录反应预测RNA病毒的广谱抗病毒药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=068319115937)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278898, encodeId=03fc12e889821, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Preprint：COVID-19在人类宿主中会进化！, objectType=article, longId=190655, objectId=9db3190655b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9db3190655b6, replyNumber=0, likeNumber=105, createdTime=2020-03-25, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9db3190655b6, moduleTitle=Preprint：COVID-19在人类宿主中会进化！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9db3190655b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278897, encodeId=498512e8897a7, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Preprint：青春痘？黄褐斑？皮肤状况之谜，肠道菌群和内分泌一起回答你！, objectType=article, longId=190472, objectId=2d301904e235, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d301904e235, replyNumber=0, likeNumber=106, createdTime=2020-03-22, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d301904e235, moduleTitle=Preprint：青春痘？黄褐斑？皮肤状况之谜，肠道菌群和内分泌一起回答你！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d301904e235)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278896, encodeId=ba1d12e8896d9, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Preprint：SARS-CoV-2感染检测新进展，RNA+血清学结合检测显锋芒, objectType=article, longId=189985, objectId=76a918998588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76a918998588, replyNumber=0, likeNumber=88, createdTime=2020-03-15, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76a918998588, moduleTitle=Preprint：SARS-CoV-2感染检测新进展，RNA+血清学结合检测显锋芒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76a918998588)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278895, encodeId=545c12e889549, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Preprints：中科院：无证据表明亚洲人新冠病毒细胞通道ACE2受体表达量更高, objectType=article, longId=188873, objectId=4b0f1888e3dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b0f1888e3dd, replyNumber=0, likeNumber=106, createdTime=2020-02-28, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b0f1888e3dd, moduleTitle=Preprints：中科院：无证据表明亚洲人新冠病毒细胞通道ACE2受体表达量更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b0f1888e3dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278894, encodeId=cec012e8894ad, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Preprints:新冠肺炎两大易感因素：肥胖和癌症，缘于ACE2表达量更高, objectType=article, longId=188801, objectId=e27a18880152, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e27a18880152, replyNumber=0, likeNumber=94, createdTime=2020-02-27, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e27a18880152, moduleTitle=Preprints:新冠肺炎两大易感因素：肥胖和癌症，缘于ACE2表达量更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e27a18880152)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278893, encodeId=3c0d12e88938e, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=FDA批准PrEP预防性疗法Descovy，以减少性传播感染HIV-1风险, objectType=article, longId=180534, objectId=eb4b180534b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb4b180534b8, replyNumber=0, likeNumber=93, createdTime=2019-10-07, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb4b180534b8, moduleTitle=FDA批准PrEP预防性疗法Descovy，以减少性传播感染HIV-1风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb4b180534b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278892, encodeId=e8e212e8892a1, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Prep Biochem Biotechnol：绿色合成的PA-AgNPs可用于生物医学领域, objectType=article, longId=142119, objectId=5b18142119ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b18142119ed, replyNumber=0, likeNumber=96, createdTime=2018-07-02, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b18142119ed, moduleTitle=Prep Biochem Biotechnol：绿色合成的PA-AgNPs可用于生物医学领域, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b18142119ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278891, encodeId=822d12e889136, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=J Acq Immun Def Synd：PrEP有望使2020年HIV预防目标成功实现！, objectType=article, longId=123461, objectId=e54b123461a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e54b123461a5, replyNumber=0, likeNumber=107, createdTime=2017-12-16, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e54b123461a5, moduleTitle=J Acq Immun Def Synd：PrEP有望使2020年HIV预防目标成功实现！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e54b123461a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278890, encodeId=42df12e8890aa, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=吉利德HIV药物Truvada（特鲁瓦达）获英国NICE支持用于HIV暴露前预防治疗（PrEP）, objectType=article, longId=79467, objectId=3f80e946793, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f80e946793, replyNumber=0, likeNumber=108, createdTime=2016-10-09, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f80e946793, moduleTitle=吉利德HIV药物Truvada（特鲁瓦达）获英国NICE支持用于HIV暴露前预防治疗（PrEP）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f80e946793)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278889, encodeId=46df12e888903, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=PLOS Med：放心啪啪啪？ART联合PrEP可近100%的阻止HIV的传播, objectType=article, longId=75968, objectId=dff8e596851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dff8e596851, replyNumber=0, likeNumber=78, createdTime=2016-08-28, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dff8e596851, moduleTitle=PLOS Med：放心啪啪啪？ART联合PrEP可近100%的阻止HIV的传播, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dff8e596851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278888, encodeId=eaf212e888802, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=Peptides：能量平衡调节的新三剑客：Adropin、Preptin和 Irisin, objectType=article, longId=43376, objectId=1ea7433e61e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ea7433e61e, replyNumber=0, likeNumber=92, createdTime=2014-12-02, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ea7433e61e, moduleTitle=Peptides：能量平衡调节的新三剑客：Adropin、Preptin和 Irisin, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ea7433e61e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278887, encodeId=739c12e8887af, content=<a href='/topic/show?id=de7e14645e6' target=_blank style='color:#2F92EE;'>#PrEP#</a>, objectTitle=JAMA：PrEP疗法或不能消除HIV对怀孕的影响, objectType=article, longId=38078, objectId=a3d8380e848, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3d8380e848, replyNumber=0, likeNumber=113, createdTime=2014-07-23, rootId=0, userName=yangeasy, userId=e12a151, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3d8380e848, moduleTitle=JAMA：PrEP疗法或不能消除HIV对怀孕的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3d8380e848)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PrEP

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#HIV# #PrEP# #来那卡帕韦#

2025-03-13发表于上海

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

J Clin Oncol：神经激肽-1受体拮抗剂fosnetupitant (FosNTP)对比fosaprepitant (FosAPR)预防高致吐性化疗引起的恶心和呕吐的有效性和安全性

2021-11-24

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Lancet Infect Dis：cabotegravir的PrEP方案可将HIV发病率降低66％

2020-07-10

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Preprint：来自25个国家的研究：高咖啡摄入量竟会降低胃癌风险

2020-05-22

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Preprint：为什么COVID-19在欧洲的传播比在亚洲更广泛

2020-05-15

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Preprint：吸烟状态与COVID-19严重程度呈正比

2020-04-29

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Preprints: 利用对外源性RNA的转录反应预测RNA病毒的广谱抗病毒药

2020-04-02

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Preprint：COVID-19在人类宿主中会进化！

2020-03-25

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Preprint：青春痘？黄褐斑？皮肤状况之谜，肠道菌群和内分泌一起回答你！

2020-03-22

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Preprint：SARS-CoV-2感染检测新进展，RNA+血清学结合检测显锋芒

2020-03-15

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Preprints：中科院：无证据表明亚洲人新冠病毒细胞通道ACE2受体表达量更高

2020-02-28

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Preprints:新冠肺炎两大易感因素：肥胖和癌症，缘于ACE2表达量更高

2020-02-27

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

FDA批准PrEP预防性疗法Descovy，以减少性传播感染HIV-1风险

2019-10-07

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Prep Biochem Biotechnol：绿色合成的PA-AgNPs可用于生物医学领域

2018-07-02

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

J Acq Immun Def Synd：PrEP有望使2020年HIV预防目标成功实现！

2017-12-16

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

吉利德HIV药物Truvada（特鲁瓦达）获英国NICE支持用于HIV暴露前预防治疗（PrEP）

2016-10-09

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

PLOS Med：放心啪啪啪？ART联合PrEP可近100%的阻止HIV的传播

2016-08-28

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

Peptides：能量平衡调节的新三剑客：Adropin、Preptin和 Irisin

2014-12-02

yangeasy (审核中...)

前往app查看评论内容

#PrEP#

JAMA：PrEP疗法或不能消除HIV对怀孕的影响

2014-07-23

科室
- - 订阅+
  - 更多科室
工具
服务